ConductScience.org, home

Paper1089613

Benurestat, a urease inhibitor for the therapy of infected ureolysis.

Andersen JA. Invest Urol, 1975. Cited by 25 papers, by iCite.

Cite this record

ConductScience Library. Benurestat, a urease inhibitor for the therapy of infected ureolysis. Papers, record 1089613. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1089613

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Benurestat, a urease inhibitor for the therapy of infected ureolysis.
PubMed
Journal
Invest Urol
PubMed
Year
1975
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
1.29
iCite
Revised in PubMed
2013-11-21
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Andersen JAJ A

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hydroxamic AcidsMajor topic
Proteus InfectionsMajor topic
UreaMajor topic
UreaseMajor topic
Urinary CalculiMajor topic
Urinary Tract InfectionsMajor topic
Ammonia
Ampicillin
Animals
Benzamides
Dose-Response Relationship, Drug
Drug Evaluation
Humans
Nitrofurantoin
Proteus mirabilis
Rats
Sulfamethoxazole

Source PubMed

Download CSV of topics

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
39778875A Small-Molecule Inhibitor of Gut Bacterial Urease Protects the Host from Liver Injury.ACS Chem Biol2025https://conductscience.org/library/papers/39778875PubMed
33553205Encrusted Uropathy: A Comprehensive Overview-To the Bottom of the Crust.Front Med (Lausanne)2020https://conductscience.org/library/papers/33553205PubMed
7012032Role of urease in the formation of infection stones: comparison of ureases from different sources.Infect Immun1981https://conductscience.org/library/papers/7012032PubMed
6758273Treatment of infected urinary stones in rats by a new hydroxamic acid, "N-(pivaloyl)glycinohydroxamic acid.Urol Res1982https://conductscience.org/library/papers/6758273PubMed
6549013Stone formation by Ureaplasma urealyticum in human urine and its prevention by urease inhibitors.J Clin Microbiol1984https://conductscience.org/library/papers/6549013PubMed
3771124S.E.M. study of urease-induced crystalluria in the presence of hydroxamic derivatives.Int Urol Nephrol1986https://conductscience.org/library/papers/3771124PubMed
10828Effect of organic mercurials and sulfhydryl compounds on the urease activity of Proteus: inhibition by urine and ascorbic acid.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/10828PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1089613

GET https://conductscience.org/api/papers/v1/1089613/authors